Maristella Bianconi

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

Andrea Lunardi, Ugo Ala, Mirjam T. Epping et al. · Nature Genetics · 2013 · 144 citations · Full text

Medicine, Oncology, Urology +17

VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE‐1 study

Mario Scartozzi, Luca Faloppi, Gianluca Svegliati‐Baroni et al. · International Journal of Cancer · 2014 · 135 citations · Full text

Medicine, Genetics, Oncology +17

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients

Mario Scartozzi, Riccardo Giampieri, Elena Maccaroni et al. · British Journal of Cancer · 2012 · 109 citations · Full text

Medicine, Oncology, Pharmacology +17

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management

Luca Faloppi, Mario Scartozzi, Maristella Bianconi et al. · BMC Cancer · 2014 · 98 citations · Full text

Medicine, Oncology, Pharmacology +17

VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib

Mario Scartozzi, Maristella Bianconi, Luca Faloppi et al. · British Journal of Cancer · 2012 · 78 citations · Full text

Medicine, Oncology, Cancer Genetics +16